RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Momoh Yakubu to Luteolin

This is a "connection" page, showing publications Momoh Yakubu has written about Luteolin.
Connection Strength

1.642
  1. Awoyomi OV, Adeoye YD, Oyagbemi AA, Ajibade TO, Asenuga ER, Gbadamosi IT, Ogunpolu BS, Falayi OO, Hassan FO, Omobowale TO, Arojojoye OA, Ola-Davies OE, Saba AB, Adedapo AA, Oguntibeju OO, Yakubu MA. Luteolin mitigates potassium dichromate-induced nephrotoxicity, cardiotoxicity and genotoxicity through modulation of Kim-1/Nrf2 signaling pathways. Environ Toxicol. 2021 Nov; 36(11):2146-2160.
    View in: PubMed
    Score: 0.794
  2. Oyagbemi AA, Omobowale TO, Ola-Davies OE, Asenuga ER, Ajibade TO, Adejumobi OA, Afolabi JM, Ogunpolu BS, Falayi OO, Saba AB, Adedapo AA, Yakubu MA. Luteolin-mediated Kim-1/NF-kB/Nrf2 signaling pathways protects sodium fluoride-induced hypertension and cardiovascular complications. Biofactors. 2018 Nov; 44(6):518-531.
    View in: PubMed
    Score: 0.661
  3. Oyagbemi AA, Adejumobi OA, Ajibade TO, Asenuga ER, Afolabi JM, Ogunpolu BS, Falayi OO, Hassan FO, Nabofa EW, Olutayo Omobowale T, Ola-Davies OE, Saba AB, Adedapo AA, Oguntibeju OO, Yakubu MA. Luteolin Attenuates Glycerol-Induced Acute Renal Failure and Cardiac Complications Through Modulation of Kim-1/NF-?B/Nrf2 Signaling Pathways. J Diet Suppl. 2021; 18(5):543-565.
    View in: PubMed
    Score: 0.187
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support